Gorav Jindal, Partner, Antitrust/International Competition | Akin

Gorav Jindal

Partner

Areas of Focus

Gorav Jindal, Partner, Antitrust/International Competition | Akin

Gorav Jindal

Partner

gjindal@akingump.com

Areas of Focus

Save as PDF

Share This Biography

LinkedIn

Biography
  • Co-leads the firm’s antitrust/competition practice.
  • Provides practical and innovative antitrust counsel to clients in a variety of industries, with a particular focus on the energy and pharmaceutical industries.
  • Twenty years of antitrust experience, including serving in the Federal Trade Commission’s (FTC’s) Bureau of Competition.

Gorav is a skilled antitrust lawyer with hands-on knowledge of agency practice, procedure and personnel. He combines the quantitative analysis of a background in engineering and economics with the persuasive skills of a litigator and nationally ranked intercollegiate debater. Gorav guides clients past antitrust obstacles, providing creative and innovative antitrust analyses, whether in defense of a potential or consummated transaction or as a counselor on the full range of business practices. His work led to his appointment as co-chair of the firm’s Innovation Committee.

Gorav’s practice combines government and private sector experience on behalf of clients in a variety of industries. He handles all phases of merger investigations conducted by the U.S. Department of Justice (DOJ) and the FTC. He has navigated clients through the antitrust aspects of transformative transactions and antitrust litigation, and was a vital member of the team that won Global Competition Review’s antitrust “Matter of the Year” award in 2014.

He focuses in particular on the pharmaceutical and energy industries and has represented large and small pharmaceutical companies under investigation by the FTC for price-fixing, improperly listing patents in the Orange Book, and entering into illegal patent settlements, as well as allegations of business practices designed to unfairly lengthen the life-cycle of branded drugs under the Hatch-Waxman Act. In 2017, Legal 500 US noted his “particular expertise in antitrust issues connected with the pharmaceuticals sector.”

Gorav also has experience in handling antitrust litigation matters. He has assisted in the development of litigation strategy for preliminary injunction hearings and complex commercial litigation. He represents clients that have been targeted in criminal antitrust proceedings, focusing on the plausibility of criminal theories and assessing the likelihood of indictments and convictions.

Prior to joining private practice, Gorav served in the FTC’s Bureau of Competition. He investigated a number of highly publicized transactions, including mergers in the publishing, computer hardware and chemical industries.

Representative Work
  • Serving as lead antitrust counsel in the auction of one of the largest equipment rental companies and its ensuing $1.3 billion sale to the largest company in the industry; led the strategy that resulted in quicker merger clearance than other past transactions in the same industry.
  • Representing a network airline carrier in its merger with another network airline carrier.
  • Securing unconditional clearance for a leading fossil-fuel producer in the sale of certain assets to a nearby rival.
  • Formulating the antitrust strategy to obtain international clearance in the hostile takeover of a large fossil-fuel producer by a leading global producer in the same industry.
  • Securing unconditional clearance for a leading integrated pharmaceutical drug pharmacy in its acquisition of the largest specialized nationalized pharmacy in its segment.
  • Representing a dialysis provider in a sale to a rival.
  • Representing a diversified pharmaceutical company in the sale of its consumer health products division to a leading global competitor.
  • Representing a pharmaceutical company in a $1.9 billion acquisition.
  • Representing a Global Distribution Systems (GDS) service provider in a second-phase investigation conducted by the DOJ.
  • Representing a supermarket chain against the FTC’s efforts to block its acquisition of another supermarket chain.
  • Representing a domestic dairy processor in its $2.5 billion acquisition.

Education
  • J.D., The George Washington University Law School, 1998

  • B.S., University of Michigan, 1995

  • B.A., University of Michigan, 1995

Bar Admissions
  • District of Columbia

  • New Jersey

Recognitions
  • The Legal 500 US, Antitrust: Merger Control, 2017-2024; Antitrust: Cartel, 2020; Antitrust: Civil Litigation/Class Actions: Defense, 2022-2023.
Speeches and Publications
  • Presenter, “Antitrust Trends in the Semiconductor Industry: A Review of Developments in the U.S., EU/UK and China,” General Counsel Roundtable, Semiconductor Industry Association, January 21, 2021.
  • “Complex Litigation During a Pandemic: Lessons from a Recently Completed Federal Bench Trial,” Akin Webinar, August 2020.
  • “Getting the Deal Done: Hot Topics in Antitrust Enforcement of Mergers,” Akin CLE Seminar, Dallas and Houston, November 2017.
  • “U.S. Antitrust Outlook in the New Administration,” Texas General Counsel Forum, Dallas, October 2017.
  • “Latest Trends in Merger Enforcement,” June 2016.

Insights and Achievements

          Related Content

          People

          Distinguished by our areas of focus, as a cohesive and integrated firm, we are defined by the caliber of our work, the responsiveness of our service and a culture that is rooted in collaboration and forward-thinking.

          We Also Recommend

          Loading...
          Loading...
          Loading...
          Loading...